Organon To Pay $31 Million Over FCA Medicaid Allegations
Drug manufacturer Organon USA Inc. has agreed to pay $31 million to settle allegations from the federal government and several states, including New York and Kentucky, that it underpaid rebates to...To view the full article, register now.
Already a subscriber? Click here to view full article